CV

Investment firm

CureDuchenne Ventures

Private equity

WebsiteCrunchbase profileBrookline·Massachusetts·United States8known portfolio companies1person tracked13co-investors

CureDuchenne Ventures is a private equity firm. The one team member on file is in Brookline, Massachusetts, United States. Known portfolio companies include PepGen, Entos Pharmaceuticals, Myosana Therapeutics, Code Biotherapeutics, MyoGene Bio and Insmed, 8 companies in all.

Is CureDuchenne Ventures a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Who to pitch at CureDuchenne Ventures

CureDuchenne Ventures portfolio companies (8)

  • PepGen
  • Entos Pharmaceuticals
  • Myosana Therapeutics
  • Code Biotherapeutics
  • MyoGene Bio
  • Insmed
  • Entrada Therapeutics
  • Gennao Bio

Co-investors

Funds that share portfolio companies with CureDuchenne Ventures.

Similar funds

Showing 20 of 100

About CureDuchenne Ventures

The firm's listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Discovery and Genetics; known deals cluster at Late-Stage.

Po Ting Liu (Associate) is listed as the contact to pitch at CureDuchenne Ventures.

Across the known portfolio, 13 co-investors appear alongside CureDuchenne Ventures, including Parent Project Muscular Dystrophy, California Institute for Regenerative Medicine and Duchenne UK.

Frequently asked questions

What is CureDuchenne Ventures?

CureDuchenne Ventures is a private equity firm whose one person on file is in Brookline, Massachusetts, United States, with a known portfolio of 8 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does CureDuchenne Ventures invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Discovery and Genetics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does CureDuchenne Ventures invest at?

The known deals of CureDuchenne Ventures include Late-Stage rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at CureDuchenne Ventures?

One person at CureDuchenne Ventures is on file, listed as a contact for the firm, with their own profile page.

How do I contact CureDuchenne Ventures?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal